125 related articles for article (PubMed ID: 2129603)
1. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
Berk RS; Preston M; Montgomery IN; Hazlett LD; Tse HY
Reg Immunol; 1990-1991; 3(4):186-92. PubMed ID: 2129603
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody and ocular responses to murine corneal infection caused by Pseudomonas aeruginosa.
Berk RS; Montgomery IN; Hazlett LD
Infect Immun; 1988 Dec; 56(12):3076-80. PubMed ID: 3141279
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa.
Preston MJ; Kernacki KA; Berk JM; Hazlett LD; Berk RS
Infect Immun; 1992 Mar; 60(3):885-91. PubMed ID: 1541561
[TBL] [Abstract][Full Text] [Related]
6. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
7. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
8. MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.
Kernacki KA; Barrett RP; McClellan S; Hazlett LD
J Leukoc Biol; 2001 Dec; 70(6):911-9. PubMed ID: 11739554
[TBL] [Abstract][Full Text] [Related]
9. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
Preston MJ; Berk JM; Hazlett LD; Berk RS
Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for detection of antibody to Pseudomonas aeruginosa and measurement of antibody titer in horse serum.
Ueda Y; Sanai Y; Homma JY
Am J Vet Res; 1982 Jan; 43(1):55-60. PubMed ID: 6807144
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa.
Preston MJ; Kernack K; Berk RS
Infect Immun; 1993 Jun; 61(6):2713-6. PubMed ID: 8500912
[TBL] [Abstract][Full Text] [Related]
13. Differential specific humoral response of susceptible and resistant mice infected with Mycobacterium lepraemurium.
Martínez-Abraján DM
Rev Latinoam Microbiol; 1993; 35(2):171-6. PubMed ID: 8209112
[TBL] [Abstract][Full Text] [Related]
14. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
15. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
McClellan SA; Zhang Y; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
[TBL] [Abstract][Full Text] [Related]
16. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
18. Aging and PMN response to P. aeruginosa infection.
Kernacki KA; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3019-25. PubMed ID: 10967059
[TBL] [Abstract][Full Text] [Related]
19. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
Markham RB; Pier GB; Schreiber JR
J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
[TBL] [Abstract][Full Text] [Related]
20. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
Kernacki KA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
